Aerobic exercise in HIV-associated neurocognitive disorders : protocol for a randomized controlled trial

dc.contributor.authorNweke, Martins C.
dc.contributor.authorMshunqane, Nombeko
dc.contributor.authorGovender, Nalini
dc.contributor.authorAkinpelu, Aderonke
dc.contributor.authorOgunniyi, Adesola
dc.date.accessioned2022-12-15T09:57:50Z
dc.date.available2022-12-15T09:57:50Z
dc.date.issued2022-01-31
dc.descriptionSUPPLEMENTARY MATERIALS : APPENDIX 1. Beck Depression Inventory.en_US
dc.descriptionAPPENDIX 2. Alcohol Use Disorder Identification Test (AUDIT).en_US
dc.descriptionAPPENDIX 3. Drug Abuse Screening Test.en_US
dc.descriptionAPPENDIX 4. International HIV Dementia Scale.en_US
dc.descriptionAPPENDIX 5. Controlled Oral Word Association Test (COWAT) (Verbal Fluency Test).en_US
dc.descriptionAPPENDIX 6. Hopkin Verbal Learning Test-Revised.en_US
dc.descriptionAPPENDIX 7. Trail Making Test A & B.en_US
dc.descriptionAPPENDIX 8. Digit span test.en_US
dc.descriptionAPPENDIX 9. Lawton Instrumental Activities of Daily Living (IADL) scale.en_US
dc.descriptionAPPENDIX 10. The World Health Organization Quality of Life (WHOQoL) Bref.en_US
dc.descriptionAPPENDIX 11. Oxford Participation and Activities Questionnaire (Ox-PAQ).en_US
dc.descriptionAPPENDIX 12. Physical Activity Readiness Questionnaire.en_US
dc.descriptionAPPENDIX 13. Adverse events form.en_US
dc.description.abstractBACKGROUND : Since the introduction of antiretroviral therapy (ART), the incidence of HIV-associated dementia has drastically fallen. Despite using ART, people living with HIV continue to experience less severe but limiting forms of HIV-associated neurocognitive disorder (HAND). People living with HIV who are on ART and experiencing symptoms of HAND may benefit from aerobic exercise. OBJECTIVE : This protocol describes a randomized controlled trial designed to determine the effects of a 12-week aerobic exercise program on HAND in Southeastern Nigeria. METHODS : At least 68 patients diagnosed with HAND will be randomly placed into either an aerobic exercise group or control group. Patients in the aerobic exercise group will perform a moderate intensity workout on a stationary bicycle ergometer, 3 times a week for 12 weeks. We will measure the primary outcomes including neurocognitive performance, prevalence of HAND, viral load, and CD4 count. We will evaluate postexercise neurocognitive performance using reliable neuropsychological tests relevant to people living with HIV, in line with the Frascati criteria. We will assess secondary outcomes such as quality of life, activity limitation, and social participation using the World Health Organization Quality of Life (WHOQOL)-Brief, and the Oxford Participation and Activities questionnaire. We will use exploratory statistics to test the data for normality and homogeneity. We will analyze the effect of the exercise program on HAND using relative risk (RR) and absolute risk reduction (number needed to treat). Analysis of covariance will be run to estimate the effect of exercise on quality of life and activity and participation level. RESULTS : This funded trial was approved by the Institutional Review Board in May 2020. The protocol was approved on June 15, 2020. Enrollment commenced in January 2021 and was completed in May 2021. Over 60% of the participants were recruited at the time of first submission to JMIR Mental Health. Data curation is still ongoing; hence, data analysis is yet to be executed. Study outcomes are expected to be published in March 2022. CONCLUSIONS : This is a protocol for a randomized controlled trial that aims to evaluate the effect of a 12-week aerobic exercise program on HAND in Southeastern Nigeria.en_US
dc.description.departmentPhysiotherapyen_US
dc.description.sponsorshipThe National Student Financial Aid Scheme (NSFAS) via the University Pretoria Doctoral Research Bursary.en_US
dc.description.urihttp://www.researchprotocols.orgen_US
dc.identifier.citationNweke, M., Mshunqane, N.., Govender, N., Akinpelu, A. & Ogunniyi, A. Aerobic Exercise in HIV-Associated Neurocognitive Disorders: Protocol for a Randomized Controlled Trial. JMIR Research Protocols 2022;11(1):e29230, doi: 10.2196/29230.en_US
dc.identifier.issn1929-0748 (online)
dc.identifier.other10.2196/29230
dc.identifier.urihttps://repository.up.ac.za/handle/2263/88826
dc.language.isoenen_US
dc.publisherJMIR Publicationsen_US
dc.rights© Martins Nweke, Nombeko Mshunqane, Nalini Govender, Aderonke Akinpelu, Adesola Ogunniyi. This is an open-access article distributed under the terms of the Creative Commons Attribution License.en_US
dc.subjectNeurocognitive disorderen_US
dc.subjectExerciseen_US
dc.subjectRehabilitationen_US
dc.subjectActivity limitationen_US
dc.subjectHuman immunodeficiency virus (HIV)en_US
dc.subjectPeople living with HIV (PLHIV)en_US
dc.subjectAntiretroviral therapy (ART)en_US
dc.subjectHIV-associated neurocognitive disorder (HAND)en_US
dc.subjectQuality of life (QoL)en_US
dc.titleAerobic exercise in HIV-associated neurocognitive disorders : protocol for a randomized controlled trialen_US
dc.typeArticleen_US

Files

Original bundle

Now showing 1 - 5 of 14
Loading...
Thumbnail Image
Name:
Nweke_Aerobic_2022.pdf
Size:
251.31 KB
Format:
Adobe Portable Document Format
Description:
Article
Loading...
Thumbnail Image
Name:
Nweke_AerobicApp1_2022.pdf
Size:
44.64 KB
Format:
Adobe Portable Document Format
Description:
Appendix 1
Loading...
Thumbnail Image
Name:
Nweke_AerobicApp2_2022.pdf
Size:
280.15 KB
Format:
Adobe Portable Document Format
Description:
Appendix 2
Loading...
Thumbnail Image
Name:
Nweke_AerobicApp3_2022.pdf
Size:
117.49 KB
Format:
Adobe Portable Document Format
Description:
Appendix 3
Loading...
Thumbnail Image
Name:
Nweke_AerobicApp4_2022.pdf
Size:
574.39 KB
Format:
Adobe Portable Document Format
Description:
Appendix 4

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.75 KB
Format:
Item-specific license agreed upon to submission
Description: